Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $178,860 - $229,977
-3,300 Reduced 35.48%
6,000 $414,000
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $453,096 - $608,499
9,300 New
9,300 $512,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Castle Knight Management LP Portfolio

Follow Castle Knight Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Knight Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Castle Knight Management LP with notifications on news.